OR SB1504

Expands epinephrine administration in schools beyond autoinjectors to include intranasal devices and other delivery methods identified by the State Board of Education

Defines "premeasured dose" as a fixed amount of medication administered by autoinjector, intranasal device, or other approved method

Requires school district boards to update policies allowing K-12 students with asthma or severe allergies to self-administer medication using these broader delivery methods

Updates training requirements for school personnel and health care professionals to cover premeasured dose administration rather than only injection-based methods

Maintains existing civil and criminal liability protections for school administrators, nurses, teachers, and other employees who administer epinephrine in good faith to individuals experiencing severe allergic reactions